Cargando…
中国人群肺鳞癌患者免疫治疗疗效及不良反应观察
BACKGROUND AND OBJECTIVE: Immune checkpoint inhibitors (ICIs) improved survival of partial patients with lung squamous cell carcinoma (LUSC). However, it was still insufficient of data in older patients. This study aimed to investigate the efficacy and toxicity of immunotherapy in patients with LUSC...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346147/ https://www.ncbi.nlm.nih.gov/pubmed/35899455 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.36 |